BioSenic SA (@BioSenicSA) header
BioSenic SA (@BioSenicSA) profile picture

BioSenic is an innovative company with the objective of addressing important unmet medical needs in innate immunity, inflammation and organ/function repair.

Mont-St-Guibert, Belgium
Joined September 2012
Photo by BioSenic SA (@BioSenicSA)Photo by BioSenic SA (@BioSenicSA)Photo by BioSenic SA (@BioSenicSA)Photo by BioSenic SA (@BioSenicSA)Photo by BioSenic SA (@BioSenicSA)Photo by BioSenic SA (@BioSenicSA)Photo by BioSenic SA (@BioSenicSA)Photo by BioSenic SA (@BioSenicSA)Photo by BioSenic SA (@BioSenicSA)Photo by BioSenic SA (@BioSenicSA)
Press Release: @BioSenicSA publishes new evidence of beneficial effects of arsenic trioxide treatment supporting clinical trial for systemic sclerosis. To read more, visit: biosenic.com/sites/default/f… #arsenictrioxide #systemicsclerosis
1
1
399
Phase II success for autoimmune disease platform in GVHD ddw-online.com/phase-ii-succ… #DrugDiscovery @BioSenicSA
3
3
BioSenic SA retweeted
François Rieger préside désormais aux destinées de @BioSenicSA, la société née de la fusion entre #BoneTherapeutics et Medsenic. Il revient sur la philosophie de ce rapprochement 👇 lecho.be/entreprises/pharma-… Par @GossetOlivier1
BioSenic SA retweeted
[#CommuniquéDePresse] @BoneTherapeutic entame une nouvelle histoire sur #Euronext et devient BioSenic, suite à l'acquisition d'une participation majoritaire à hauteur de 40 M€ dans Medsenic $BOTHE #biotech #orthopédie #maladies #therapiecellulaire

2
5
Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study. bit.ly/2yXRaP2
2
3
$CYAD #CELYAD BONE THERAPEUTICS (CORPORATE, FV EUR6) | Additional EUR4m raised, cash runway expanded into Q2 2021:: BONE THERAPEUTICS (CORPORATE, FV EUR6) | Additional EUR4m raised, cash runway expanded into Q2 2021: dlvr.it/RW9KLq #equity #stocks
1
1
BioSenic SA retweeted
BONE THERAPEUTICS sécurise un financement de 11 M€ buff.ly/2xoJDI8 @BoneTherapeutic
1
1
Un ballon d'oxygène indispensable pour Bone Therapeutics #BoneTherapeutics $BOTHE @BoneTherapeutic lecho.be/dossier/biotechs/un…
3
1
BioSenic SA retweeted
#BioWinMember @BoneTherapeutic today announces that it secured EUR 11.0 million financing. The financing will be used to advance both of its key assets, ALLOB and JTA-004, through late stage clinical development. Read the full press release lnkd.in/dXshDcv
3
5
BioSenic SA retweeted
#biotech | La trésorerie de Bone Therapeutics suffisante jusqu'au 3e trimestre ➡ bit.ly/2TO2NzQ 🖌 Par @stephanewuille @BoneTherapeutic
2
1
Live from the session about #clinicaltrials #funding, led by Stefaan Pijls @ayming_be organised by @BioWin_asbl and flanders.bio Guillaume de Viron beLean.net, Jean-Luc Vandebroek @BoneTherapeutic & Annemie Ribbens @icometrix #Innovation #Grant
Replying to @BioSenicSA
@BoneTherapeutic announces the appointment of Dr. Miguel Forte as CEO to lead the Company into the next phase of development: bit.ly/2tsXFpG
BioSenic SA retweeted
Throwback on the Life Science Seminar last week in China! Pleased that we had the opportunity to present BioWin & the Walloon #LifeScience ecosystem. Great success during the pitching sessions & let’s hope the many B2B meetings will lead to great collaborations! #BEmissionCHN
BioSenic SA retweeted
Jean Stéphenne, président de @BoneTherapeutic était l'invité de Martin Buxant dans la Matinale LN24. @Le_Bux #LN24
1
3
2
7
#Bourse #biotech #celltherapy @BoneTherapeutic publie ses résultats financiers à 9 mois et fait le point sur son activité du T3 2019 Lire le communiqué bit.ly/2JUC6DU
1
1
BioSenic SA retweeted
#BIOEurope is going to Hamburg, Germany! Raise your hand if you will be there? 🙋‍♂️🙋

13
8
16
39
Belgian top notch biotech presented at 2nd #RegMed Seminar in #Tokyo, co-organised by @InvestFlanders & @AWEX_Asia @flandersbio @BioWin_asbl #BioJapan with keynotes from @Promethera @Novosanis @BoneTherapeutic @AesculapeC @RousselotGlobal @VIBLifeSciences @BelgiumMFA
7
14
#InvestirDay - Venez rencontrer @BoneTherapeutic le 3 octobre 2019 au Caroussel du Louvre En partenariat avec @LesEchos @le_Parisien @Boursier_com @InvestirFr Formulaire d'inscription bit.ly/2zsznf6
1
3